NCT05583890Completed
A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals.
A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients Versus Age Matched Healthy Individuals Using Continuous Glucose Monitors.
Source: ClinicalTrials.gov · Last updated 4 Jun 2025
Brief summary (registry, in English)
The aim of this study is to continuously monitor blood glucose concentrations for a 7-day period in pancreatic cancer patients whilst undergoing their typical daily routines and to compare this to age matched healthy individuals. The investigators plan to carry out the study on a small subset of patients, up to 30 with pancreatic cancer (15 not undergoing chemotherapy and 15 undergoing chemotherapy) and 15 healthy individuals.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 29 (actual)
- First submitted
- 11 Oct 2022
- Start date
- 25 Aug 2022
- Primary completion date
- 21 Aug 2024
- Lead sponsor
- Lancaster University
- Diseases
- Pancreatic cancer
- NCT number
- NCT05583890
What you commit to
- Study type: Observational
- Participants enrolled: 29
- From 25 Aug 2022 to the primary completion date, 21 Aug 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planned surgery within the 7 days of wearing the monitor
- Emergency surgery
Other illness
- Any musculoskeletal, cardiovascular, or neurological disorder that could put them at risk during the protocol.
- Have diabetes at the point of diagnosis.
- Healthy control group
- Inclusion:
- No serious underlying health conditions
Lab values
- Take any medications which may alter blood glucose concentrations or insulin/glucagon concentrations, regular paracetamol intake during the study period, corticosteroids, thyroid hormones, or any anti-diabetes medication including insulin and oral hypoglycaemics.
Age
- Aged 18-85
- Age matched to pancreatic cancer patients
- Exclusion:
Other
- Pregnancy
- Part of any other trial with similar interventions
- World Health Organisation performance status of above 2.
- Pregnant
Who the study is looking for
- Aged 18-85
- Sex: male/female
- Radiological/tissue cancer diagnosis
- World Health Organisation performance status of 2 or below
- Patients with jaundice must have jaundice relieved before participating
Criteria the registry did not label
- Pancreatic cancer patients
Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| East Lancashire Hospitals Trust Coordinator of this site? Confirm its status | Blackburn | United Kingdom | Unknown status |
| Lancaster University Coordinator of this site? Confirm its status | Lancaster | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.